Carl P. Gommoll, MS
- 3Articles
- 13KReads1
- 2013–2016Active
- 10Collaborators
- 69Citations2
About
Carl P. Gommoll, MS, has authored multiple articles published between 2013 and 2016 focusing on clinical research related to major depressive disorder and generalized anxiety disorder. His work includes studies on the efficacy and safety of pharmacologic treatments such as levomilnacipran extended-release and vilazodone, with attention to functional impairment and anxiety measures. He has collaborated frequently with co-authors including Adam Ruth and William M. Greenberg.
Publications
Levomilnacipran Extended-Release Treatment in Patients With Major Depressive Disorder: Improvements in Functional Impairment Categories
June 11, 2015
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
